TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.000758024441188839	-7.18479492852929	66	41	0.10594315245478	387	907	5728,9562,5298,3707,64419,5294,200576,23533,113026,8871,5336,5333,9807,8867,51259,146850,5295,22908,5296,5297,5291,89869,5286,51447,3705,8396,5305,8897,64768,3633,5293,8503,55361,9896,3632,90809,55529,5289,5330,3635,5335	PTEN,MINPP1,PI4KB,ITPKB,MTMR14,PIK3CG,PIKFYVE,PIK3R5,PLCD3,SYNJ2,PLCG2,PLCD1,IP6K1,SYNJ1,TMEM216,PIK3R6,PIK3R1,SACM1L,PIK3R2,PI4KA,PIK3CB,PLCZ1,PIK3C2A,IP6K2,ITPK1,PIP4K2B,PIP4K2A,MTMR3,IPPK,INPP5B,PIK3CD,PIK3R3,PI4K2A,FIG4,INPP5A,PIP4P1,PIP4P2,PIK3C3,PLCB2,INPP5D,PLCG1
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.00592859574147311	-5.12796789983784	9	8	0.020671834625323	387	907	5336,5333,90809,55529,64419,5305,5330,8897	PLCG2,PLCD1,PIP4P1,PIP4P2,MTMR14,PIP4K2A,PLCB2,MTMR3
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.0180416693563341	-4.01507123224673	17	12	0.0310077519379845	387	907	113026,51259,89869,5333,5336,64419,55529,90809,5335,8897,5330,5305	PLCD3,TMEM216,PLCZ1,PLCD1,PLCG2,MTMR14,PIP4P2,PIP4P1,PLCG1,MTMR3,PLCB2,PIP4K2A
META_PWY-6368	3-phosphoinositide degradation	0.0201000916548754	-3.90703090398345	19	13	0.0335917312661499	387	907	8867,8871,22876,5728,8821,8897,3631,3635,3633,22908,55529,64419,90809	SYNJ1,SYNJ2,INPP5F,PTEN,INPP4B,MTMR3,INPP4A,INPP5D,INPP5B,SACM1L,PIP4P2,MTMR14,PIP4P1
META_PWY-6352	3-phosphoinositide biosynthesis	0.0242842649814766	-3.71792667000126	25	16	0.041343669250646	387	907	5297,5289,22908,5296,5295,55361,9896,146850,5293,23533,8503,200576,5294,5286,5298,5291	PI4KA,PIK3C3,SACM1L,PIK3R2,PIK3R1,PI4K2A,FIG4,PIK3R6,PIK3CD,PIK3R5,PIK3R3,PIKFYVE,PIK3CG,PIK3C2A,PI4KB,PIK3CB
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.0251470377835485	-3.68301517133949	27	17	0.0439276485788114	387	907	8503,23533,5293,146850,9896,55361,5295,5296,22908,5289,5297,5291,5298,5286,5294,8396,200576	PIK3R3,PIK3R5,PIK3CD,PIK3R6,FIG4,PI4K2A,PIK3R1,PIK3R2,SACM1L,PIK3C3,PI4KA,PIK3CB,PI4KB,PIK3C2A,PIK3CG,PIP4K2B,PIKFYVE
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.0309973048973499	-3.47385501707155	16	11	0.0284237726098191	387	907	50515,10090,51363,55790,135152,166012,55454,9435,26229,64131,56548	CHST11,UST,CHST15,CSGALNACT1,B3GAT2,CHST13,CSGALNACT2,CHST2,B3GAT3,XYLT1,CHST7
HUMAN_PWY-5874	heme degradation	0.0328501781516407	-3.41579811088081	4	4	0.0103359173126615	387	907	3162,644,3163,645	HMOX1,BLVRA,HMOX2,BLVRB
HUMAN_PWY-6368	3-phosphoinositide degradation	0.0355164114774238	-3.33776039418754	20	13	0.0335917312661499	387	907	3635,3633,8897,8821,3631,22908,64419,55529,90809,8867,5728,22876,8871	INPP5D,INPP5B,MTMR3,INPP4B,INPP4A,SACM1L,MTMR14,PIP4P2,PIP4P1,SYNJ1,PTEN,INPP5F,SYNJ2
HUMAN_PWY-6309	L-kynurenine degradation	0.043013762698406	-3.1462351517441	11	8	0.020671834625323	387	907	169355,8942,883,125061,56267,23498,8564,2806	IDO2,KYNU,KYAT1,AFMID,KYAT3,HAAO,KMO,GOT2
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.0540951534410736	-2.91701068233542	6	5	0.0129198966408269	387	907	978,51733,7378,1806,151531	CDA,UPB1,UPP1,DPYD,UPP2
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.0675747937525753	-2.69452023895044	8	6	0.0155038759689922	387	907	50515,166012,56548,51363,10090,9435	CHST11,CHST13,CHST7,CHST15,UST,CHST2
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.0675747937525753	-2.69452023895044	8	6	0.0155038759689922	387	907	4247,4245,4124,4122,11320,4249	MGAT2,MGAT1,MAN2A1,MAN2A2,MGAT4A,MGAT5
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.0762190339541268	-2.57414405805748	10	7	0.0180878552971576	387	907	9415,54988,2180,60481,2181,116285,51703	FADS2,ACSM5,ACSL1,ELOVL5,ACSL3,ACSM1,ACSL5
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	1371,2235,5498	CPOX,FECH,PPOX
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	1738,4967,1743	DLD,OGDH,DLST
META_PWY-7049	icosapentaenoate biosynthesis II (6-desaturase, mammals)	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	9415,2180,60481	FADS2,ACSL1,ELOVL5
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	2235,1371,5498	FECH,CPOX,PPOX
META_PWY0-1296	purine ribonucleosides degradation	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	100,55276,4860	ADA,PGM2,PNP
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	151531,7378,978	UPP2,UPP1,CDA
META_PWY-7724	icosapentaenoate biosynthesis III (8-desaturase, mammals)	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	9415,2180,60481	FADS2,ACSL1,ELOVL5
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	55276,3101,3098	PGM2,HK3,HK1
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	1738,4967,1743	DLD,OGDH,DLST
META_PWY66-162	ethanol degradation IV	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	847,217,55902	CAT,ALDH2,ACSS2
META_PWY-7511	protein ubiquitylation	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	197131,7317,55284	UBR1,UBA1,UBE2W
META_PWY-5661	GDP-glucose biosynthesis	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	3101,3098,55276	HK3,HK1,PGM2
HUMAN_PWY-6608	guanosine nucleotides degradation	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	7498,22978,4860	XDH,NT5C2,PNP
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.0773347943986957	-2.55961130307583	3	3	0.00775193798449612	387	907	100,4860,55276	ADA,PNP,PGM2
META_PWY-6569	chondroitin sulfate biosynthesis	0.0880631015956433	-2.42970165788434	18	11	0.0284237726098191	387	907	22856,50515,10090,51363,55790,135152,166012,55454,26229,56548,64131	CHSY1,CHST11,UST,CHST15,CSGALNACT1,B3GAT2,CHST13,CSGALNACT2,B3GAT3,CHST7,XYLT1
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.108518362598188	-2.22083587978489	5	4	0.0103359173126615	387	907	51733,7378,1806,978	UPB1,UPP1,DPYD,CDA
HUMAN_PWY66-375	leukotriene biosynthesis	0.108518362598188	-2.22083587978489	5	4	0.0103359173126615	387	907	4048,240,64174,4056	LTA4H,ALOX5,DPEP2,LTC4S
META_PWY66-375	leukotriene biosynthesis	0.108518362598188	-2.22083587978489	5	4	0.0103359173126615	387	907	4056,64174,240,4048	LTC4S,DPEP2,ALOX5,LTA4H
META_PWY-4081	glutathione-peroxide redox reactions	0.108518362598188	-2.22083587978489	5	4	0.0103359173126615	387	907	2876,2879,2878,2936	GPX1,GPX4,GPX3,GSR
HUMAN_PWY-7511	protein ubiquitylation	0.116886763338555	-2.14654964755201	29	16	0.041343669250646	387	907	7321,54476,7317,9039,55284,51465,55236,118424,92912,997,54926,197131,7325,27338,9246,7318	UBE2D1,RNF216,UBA1,UBA3,UBE2W,UBE2J1,UBA6,UBE2J2,UBE2Q2,CDC34,UBE2R2,UBR1,UBE2E2,UBE2S,UBE2L6,UBA7
HUMAN_LIPASYN-PWY	phospholipases	0.116886763338555	-2.14654964755201	29	16	0.041343669250646	387	907	11145,89869,5337,50640,255189,8605,283748,113026,51259,5333,23646,5336,151056,201164,5335,5330	PLAAT3,PLCZ1,PLD1,PNPLA8,PLA2G4F,PLA2G4C,PLA2G4D,PLCD3,TMEM216,PLCD1,PLD3,PLCG2,PLB1,PLD6,PLCG1,PLCB2
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.123498335819632	-2.09152759814957	7	5	0.0129198966408269	387	907	5742,10728,6916,27306,5743	PTGS1,PTGES3,TBXAS1,HPGDS,PTGS2
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	0.123498335819632	-2.09152759814957	7	5	0.0129198966408269	387	907	142891,55512,6609,259230,166929	SAMD8,SMPD3,SMPD1,SGMS1,SGMS2
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.123498335819632	-2.09152759814957	7	5	0.0129198966408269	387	907	56548,51363,10090,50515,166012	CHST7,CHST15,UST,CHST11,CHST13
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.123498335819632	-2.09152759814957	7	5	0.0129198966408269	387	907	169355,23498,8942,8564,125061	IDO2,HAAO,KYNU,KMO,AFMID
META_PWY66-374	C20 prostanoid biosynthesis	0.123498335819632	-2.09152759814957	7	5	0.0129198966408269	387	907	6916,5742,10728,27306,5743	TBXAS1,PTGS1,PTGES3,HPGDS,PTGS2
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	0.130942366818623	-2.03299800053592	9	6	0.0155038759689922	387	907	56267,23498,2806,8942,8564,883	KYAT3,HAAO,GOT2,KYNU,KMO,KYAT1
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.131316702922496	-2.03014329386393	19	11	0.0284237726098191	387	907	56894,256356,8760,10555,84803,253558,137964,2710,10162,1040,56895	AGPAT3,GK5,CDS2,AGPAT2,GPAT3,LCLAT1,GPAT4,GK,LPCAT3,CDS1,AGPAT4
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.134328258651803	-2.00746878320271	11	7	0.0180878552971576	387	907	8942,8564,64802,23498,169355,23475,125061	KYNU,KMO,NMNAT1,HAAO,IDO2,QPRT,AFMID
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	240,5743	ALOX5,PTGS2
META_PWY-6076	vitamin D3 biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	120227,5447	CYP2R1,POR
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	5743,240	PTGS2,ALOX5
META_PWY-5874	heme degradation	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	644,3162	BLVRA,HMOX1
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	240,5743	ALOX5,PTGS2
HUMAN_PWY-6566	chondroitin biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	55454,55790	CSGALNACT2,CSGALNACT1
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	5743,240	PTGS2,ALOX5
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	55163,8566	PNPO,PDXK
META_PWY6666-2	dopamine degradation	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	1312,4128	COMT,MAOA
META_PWY-7343	UDP-glucose biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	55276,7360	PGM2,UGP2
META_PWY-6370	ascorbate recycling (cytosolic)	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	2745,9446	GLRX,GSTO1
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	5743,240	PTGS2,ALOX5
META_PWY-6117	spermine and spermidine degradation I	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	54498,6303	SMOX,SAT1
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	7378,978	UPP1,CDA
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	9446,2745	GSTO1,GLRX
META_PWY-7179-1	purine deoxyribonucleosides degradation II	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	100,4860	ADA,PNP
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	4860,100	PNP,ADA
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	5743,240	PTGS2,ALOX5
META_PWY-4041	gamma-glutamyl cycle	0.181786984235898	-1.70491969366367	2	2	0.00516795865633075	387	907	2729,2730	GCLC,GCLM
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.183965731164349	-1.69300578239068	20	11	0.0284237726098191	387	907	3707,3632,54928,3635,3633,3613,8871,22876,5728,9562,8867	ITPKB,INPP5A,IMPAD1,INPP5D,INPP5B,IMPA2,SYNJ2,INPP5F,PTEN,MINPP1,SYNJ1
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.207950571014807	-1.57045486687341	12	7	0.0180878552971576	387	907	55790,26229,135152,64131,10090,51363,55454	CSGALNACT1,B3GAT3,B3GAT2,XYLT1,UST,CHST15,CSGALNACT2
HUMAN_PWY-4261	glycerol degradation	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	2820,2710,256356	GPD2,GK,GK5
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	4191,2806,4190	MDH2,GOT2,MDH1
HUMAN_PWY66-162	ethanol degradation IV	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	55902,217,847	ACSS2,ALDH2,CAT
META_PWY-6608	guanosine nucleotides degradation III	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	7498,22978,4860	XDH,NT5C2,PNP
META_PWY-7592	arachidonate biosynthesis III (6-desaturase, mammals)	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	9415,2180,60481	FADS2,ACSL1,ELOVL5
HUMAN_PWY-6292	cysteine biosynthesis	0.210788643139119	-1.55689933881786	4	3	0.00775193798449612	387	907	27430,4144,875	MAT2B,MAT2A,CBS
HUMAN_PWY-6353	purine nucleotides degradation	0.213027366116206	-1.54633464210668	10	6	0.0155038759689922	387	907	7498,3615,51251,100,22978,4860	XDH,IMPDH2,NT5C3A,ADA,NT5C2,PNP
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.216704239265716	-1.52922180779908	8	5	0.0129198966408269	387	907	51251,100,7498,22978,4860	NT5C3A,ADA,XDH,NT5C2,PNP
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.216704239265716	-1.52922180779908	8	5	0.0129198966408269	387	907	210,211,5498,2235,1371	ALAD,ALAS1,PPOX,FECH,CPOX
HUMAN_PWY-5920	heme biosynthesis	0.216704239265716	-1.52922180779908	8	5	0.0129198966408269	387	907	5498,1371,2235,210,211	PPOX,CPOX,FECH,ALAD,ALAS1
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	0.216704239265716	-1.52922180779908	8	5	0.0129198966408269	387	907	169355,23498,8564,8942,125061	IDO2,HAAO,KMO,KYNU,AFMID
META_PWY3DJ-12	ceramide de novo biosynthesis	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	171546,9517,10558,8560	SPTSSA,SPTLC2,SPTLC1,DEGS1
HUMAN_PWY-4081	glutathione redox reactions I	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	2876,2879,2878,2936	GPX1,GPX4,GPX3,GSR
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	7498,3615,4860,22978	XDH,IMPDH2,PNP,NT5C2
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	7498,3615,4860,22978	XDH,IMPDH2,PNP,NT5C2
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	25796,6120,5226,7086	PGLS,RPE,PGD,TKT
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.217364780915154	-1.5261783187289	6	4	0.0103359173126615	387	907	9517,10558,8560,171546	SPTLC2,SPTLC1,DEGS1,SPTSSA
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.225193849281197	-1.49079369534004	25	13	0.0335917312661499	387	907	2131,2137,26035,8509,9394,135152,2135,9957,51146,2134,9956,26229,64131	EXT1,EXTL3,GLCE,NDST2,HS6ST1,B3GAT2,EXTL2,HS3ST1,A4GNT,EXTL1,HS3ST2,B3GAT3,XYLT1
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.230083777950885	-1.46931178442221	36	18	0.0465116279069767	387	907	2271,5315,226,3098,5214,1743,4967,1738,3101,230,3419,4191,4190,5160,6390,50,5211,5230	FH,PKM,ALDOA,HK1,PFKP,DLST,OGDH,DLD,HK3,ALDOC,IDH3A,MDH2,MDH1,PDHA1,SDHB,ACO2,PFKL,PGK1
META_PWY-6564	heparan sulfate biosynthesis	0.234609672888602	-1.44983211220354	23	12	0.0310077519379845	387	907	9957,2135,2134,64131,9956,26229,2137,2131,26035,8509,135152,9394	HS3ST1,EXTL2,EXTL1,XYLT1,HS3ST2,B3GAT3,EXTL3,EXT1,GLCE,NDST2,B3GAT2,HS6ST1
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.234609672888602	-1.44983211220354	23	12	0.0310077519379845	387	907	89869,5333,51259,5336,5298,113026,5297,5335,5305,5330,8396,55361	PLCZ1,PLCD1,TMEM216,PLCG2,PI4KB,PLCD3,PI4KA,PLCG1,PIP4K2A,PLCB2,PIP4K2B,PI4K2A
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.255328207109474	-1.36520547470594	19	10	0.0258397932816537	387	907	3613,3633,3635,54928,3632,3707,8867,9562,5728,8871	IMPA2,INPP5B,INPP5D,IMPAD1,INPP5A,ITPKB,SYNJ1,MINPP1,PTEN,SYNJ2
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.255328207109474	-1.36520547470594	19	10	0.0258397932816537	387	907	9957,2135,2134,51146,9956,2137,2131,26035,8509,9394	HS3ST1,EXTL2,EXTL1,A4GNT,HS3ST2,EXTL3,EXT1,GLCE,NDST2,HS6ST1
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.266810753792488	-1.32121565918441	17	9	0.0232558139534884	387	907	9957,2135,2134,9956,2137,2131,26035,8509,9394	HS3ST1,EXTL2,EXTL1,HS3ST2,EXTL3,EXT1,GLCE,NDST2,HS6ST1
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	8867,8871,3635,3633,64768,3705,3632,3707	SYNJ1,SYNJ2,INPP5D,INPP5B,IPPK,ITPK1,INPP5A,ITPKB
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	8867,8871,3633,3635,64768,3632,3707,3705	SYNJ1,SYNJ2,INPP5B,INPP5D,IPPK,INPP5A,ITPKB,ITPK1
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	8867,9562,8871,5728,3635,3633,3707,3632	SYNJ1,MINPP1,SYNJ2,PTEN,INPP5D,INPP5B,ITPKB,INPP5A
META_PWY-6571	dermatan sulfate biosynthesis	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	22856,55790,135152,10090,51363,55454,26229,64131	CHSY1,CSGALNACT1,B3GAT2,UST,CHST15,CSGALNACT2,B3GAT3,XYLT1
HUMAN_PWY66-400	glycolysis	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	3101,230,5315,5211,5230,3098,5214,226	HK3,ALDOC,PKM,PFKL,PGK1,HK1,PFKP,ALDOA
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	3101,230,5315,5214,3098,5211,5230,226	HK3,ALDOC,PKM,PFKP,HK1,PFKL,PGK1,ALDOA
HUMAN_PWY66-399	gluconeogenesis	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	230,2203,5091,92579,5230,4191,4190,226	ALDOC,FBP1,PC,G6PC3,PGK1,MDH2,MDH1,ALDOA
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	8867,9562,5728,8871,3633,3635,3632,3707	SYNJ1,MINPP1,PTEN,SYNJ2,INPP5B,INPP5D,INPP5A,ITPKB
META_ANAGLYCOLYSIS-PWY	glycolysis III (from glucose)	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	226,5211,5230,5214,3098,5315,3101,230	ALDOA,PFKL,PGK1,PFKP,HK1,PKM,HK3,ALDOC
META_PWY66-399	gluconeogenesis III	0.279203980915367	-1.27581264990271	15	8	0.020671834625323	387	907	230,92579,5230,2203,5091,4190,226,4191	ALDOC,G6PC3,PGK1,FBP1,PC,MDH1,ALDOA,MDH2
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.292677924907596	-1.22868250696139	13	7	0.0180878552971576	387	907	3633,3613,8867,54928,8871,22876,3632	INPP5B,IMPA2,SYNJ1,IMPAD1,SYNJ2,INPP5F,INPP5A
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.292677924907596	-1.22868250696139	13	7	0.0180878552971576	387	907	55361,5297,5333,5298,5330,5305,5336	PI4K2A,PI4KA,PLCD1,PI4KB,PLCB2,PIP4K2A,PLCG2
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.307466295073852	-1.17938980725906	11	6	0.0155038759689922	387	907	8871,3632,3613,8867,3633,54928	SYNJ2,INPP5A,IMPA2,SYNJ1,INPP5B,IMPAD1
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.323906579825901	-1.12730013863669	9	5	0.0129198966408269	387	907	23475,8942,8564,64802,23498	QPRT,KYNU,KMO,NMNAT1,HAAO
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.323906579825901	-1.12730013863669	9	5	0.0129198966408269	387	907	4860,22978,100,7498,3615	PNP,NT5C2,ADA,XDH,IMPDH2
META_DETOX1-PWY-1	reactive oxygen species degradation	0.342520041044459	-1.07142510899331	7	4	0.0103359173126615	387	907	847,2876,6648,2878	CAT,GPX1,SOD2,GPX3
META_PWY66-398	TCA cycle III (animals)	0.362229284430038	-1.01547788525492	16	8	0.020671834625323	387	907	6390,50,1743,4190,4191,3419,4967,2271	SDHB,ACO2,DLST,MDH1,MDH2,IDH3A,OGDH,FH
HUMAN_PWY66-398	TCA cycle	0.362229284430038	-1.01547788525492	16	8	0.020671834625323	387	907	6390,50,1743,4190,3419,4191,4967,2271	SDHB,ACO2,DLST,MDH1,IDH3A,MDH2,OGDH,FH
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	60490,80347,53354	PPCDC,COASY,PANK1
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	3242,3081,2184	HPD,HGD,FAH
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	80347,53354,60490	COASY,PANK1,PPCDC
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	2184,3081,3242	FAH,HGD,HPD
META_VALDEG-PWY	L-valine degradation I	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	593,18,1738	BCKDHA,ABAT,DLD
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	23498,8564,8942	HAAO,KMO,KYNU
META_PWY-4921	protein citrullination	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	23569,29943,11240	PADI4,PADI1,PADI2
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	2650,56913,6482	GCNT1,C1GALT1,ST3GAL1
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	4706,32,27349	NDUFAB1,ACACB,MCAT
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	55163,250,8566	PNPO,ALPP,PDXK
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	10555,56894,56895	AGPAT2,AGPAT3,AGPAT4
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	4860,100,7498	PNP,ADA,XDH
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	978,1633,7084	CDA,DCK,TK2
META_PWY-6566	chondroitin biosynthesis	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	55790,22856,55454	CSGALNACT1,CHSY1,CSGALNACT2
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	978,1633,7084	CDA,DCK,TK2
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.3641940639547	-1.0100684106828	5	3	0.00775193798449612	387	907	978,7378,151531	CDA,UPP1,UPP2
META_PWY-7728	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	60481,9415	ELOVL5,FADS2
HUMAN_PWY-3982	uracil degradation	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	51733,1806	UPB1,DPYD
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	27430,4144	MAT2B,MAT2A
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4144,27430	MAT2A,MAT2B
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	978,7371	CDA,UCK2
META_PWY-6609	adenine and adenosine salvage III	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4860,100	PNP,ADA
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	275,1738	AMT,DLD
HUMAN_PWY6666-2	dopamine degradation	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4128,1312	MAOA,COMT
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4860,9446	PNP,GSTO1
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	3705,64768	ITPK1,IPPK
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4191,4190	MDH2,MDH1
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	60481,9415	ELOVL5,FADS2
META_GLYCLEAV-PWY	glycine cleavage	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	1738,275	DLD,AMT
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	4706,109703458	NDUFAB1,HTD2
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	978,7371	CDA,UCK2
META_PWY-7527	L-methionine salvage cycle III	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	883,4507	KYAT1,MTAP
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	275,1738	AMT,DLD
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	9446,4860	GSTO1,PNP
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	217,314	ALDH2,AOC2
HUMAN_PWY-6430	thymine degradation	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	1806,51733	DPYD,UPB1
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	7086,6120	TKT,RPE
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	9562,3705	MINPP1,ITPK1
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	84105,5860	PCBD2,QDPR
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	5860,84105	QDPR,PCBD2
META_PWY66-161	oxidative ethanol degradation III	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	55902,217	ACSS2,ALDH2
HUMAN_PWY-5453	methylglyoxal degradation III	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	57016,231	AKR1B10,AKR1B1
META_PWY66-21	ethanol degradation II	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	55902,217	ACSS2,ALDH2
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	25796,5226	PGLS,PGD
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	55276,2582	PGM2,GALE
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	9562,3705	MINPP1,ITPK1
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	64802,10135	NMNAT1,NAMPT
META_PWY-3982	uracil degradation I (reductive)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	1806,51733	DPYD,UPB1
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	217,3242	ALDH2,HPD
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	5226,25796	PGD,PGLS
META_PWY-7727	docosahexaenoate biosynthesis IV (4-desaturase, mammals)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	9415,60481	FADS2,ELOVL5
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	9415,2180	FADS2,ACSL1
HUMAN_PWY-6609	adenine and adenosine salvage III	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	100,4860	ADA,PNP
META_PWY-2301	myo-inositol biosynthesis	0.390691363909339	-0.939837381313509	3	2	0.00516795865633075	387	907	54928,3613	IMPAD1,IMPA2
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.406982019134302	-0.898986273546662	12	6	0.0155038759689922	387	907	9415,51703,116285,2181,2180,54988	FADS2,ACSL5,ACSM1,ACSL3,ACSL1,ACSM5
HUMAN_PWY-6399	melatonin degradation II	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	4128	MAOA
HUMAN_PWY-6173	histamine biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	3067	HDC
META_PWY-7344	UDP-D-galactose biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2582	GALE
HUMAN_MANNCAT-PWY	D-mannose degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	4351	MPI
HUMAN_PWY0-1305	glutamate dependent acid resistance	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2752	GLUL
META_PWY-7501	phosphatidylserine biosynthesis I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	9791	PTDSS1
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	883	KYAT1
META_PWY-6241	thyroid hormone biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	1509	CTSD
HUMAN_PWY-4101	sorbitol degradation I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	6652	SORD
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2936	GSR
META_PWY-6535	4-aminobutanoate degradation I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	18	ABAT
HUMAN_P121-PWY	adenine and adenosine salvage I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	353	APRT
META_PWY6666-1	anandamide degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2166	FAAH
META_GLNSYN-PWY	L-glutamine biosynthesis I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2752	GLUL
HUMAN_PWY-5148	acyl-CoA hydrolysis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	23597	ACOT9
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	9791	PTDSS1
META_PWY-7725	arachidonate biosynthesis V (8-detaturase, mammals)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	9415	FADS2
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2582	GALE
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	875	CBS
HUMAN_PWY-6535	4-aminobutyrate degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	18	ABAT
HUMAN_PWY-6619	adenine and adenosine salvage II	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	132	ADK
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	875	CBS
HUMAN_SERDEG-PWY	L-serine degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	113675	SDSL
HUMAN_GLNSYN-PWY	glutamine biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2752	GLUL
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	4507	MTAP
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	9562	MINPP1
HUMAN_PWY66-11	BMP Signalling Pathway	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	4089	SMAD4
META_PWY-6173	histamine biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	3067	HDC
META_HISHP-PWY	L-histidine degradation VI	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	3034	HAL
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	197257	LDHD
META_PWY0-1313	acetate conversion to acetyl-CoA	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	55902	ACSS2
META_GLUT-REDOX-PWY	glutathione-glutaredoxin redox reactions	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2936	GSR
META_ARGSPECAT-PWY	spermine biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	6611	SMS
HUMAN_BGALACT-PWY	lactose degradation III	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2720	GLB1
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	197257	LDHD
HUMAN_PWY-2161B	glutamate removal from folates	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	8836	GGH
HUMAN_PWY-6898	thiamin salvage III	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	27010	TPK1
META_PWY-5269	cardiolipin biosynthesis II	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	9489	PGS1
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	51699	VPS29
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	875	CBS
HUMAN_PWY-6334	L-dopa degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	1312	COMT
META_PWY-6619	adenine and adenosine salvage VI	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	132	ADK
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	2582	GALE
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	60481	ELOVL5
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	6611	SMS
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	0.426681367144681	-0.851717757084771	1	1	0.00258397932816537	387	907	4507	MTAP
HUMAN_PWY-7434	terminal O-glycans residues modification	0.468335842824208	-0.758569627553251	8	4	0.0103359173126615	387	907	6487,2651,8704,8703	ST3GAL3,GCNT2,B4GALT2,B4GALT3
HUMAN_PWY-0	putrescine degradation III	0.468335842824208	-0.758569627553251	8	4	0.0103359173126615	387	907	221,4128,217,6303	ALDH3B1,MAOA,ALDH2,SAT1
HUMAN_PWY-5328	superpathway of methionine degradation	0.504956957044503	-0.683282086914607	13	6	0.0155038759689922	387	907	5095,875,27430,1738,593,4144	PCCA,CBS,MAT2B,DLD,BCKDHA,MAT2A
META_PWY66-409	superpathway of purine nucleotide salvage	0.504956957044503	-0.683282086914607	13	6	0.0155038759689922	387	907	6240,100,3615,4860,6241,132	RRM1,ADA,IMPDH2,PNP,RRM2,ADK
META_PWY-5130	2-oxobutanoate degradation I	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	593,1738,5095	BCKDHA,DLD,PCCA
HUMAN_PWY-5143	fatty acid activation	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	2180,2181,51703	ACSL1,ACSL3,ACSL5
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	10558,9517,171546	SPTLC1,SPTLC2,SPTSSA
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	26229,64131,135152	B3GAT3,XYLT1,B3GAT2
HUMAN_PWY-5130	2-oxobutanoate degradation	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	593,1738,5095	BCKDHA,DLD,PCCA
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	26229,135152,64131	B3GAT3,B3GAT2,XYLT1
META_PWY66-428	L-threonine degradation V	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	113675,593,1738	SDSL,BCKDHA,DLD
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	10390,56994,5130	CEPT1,CHPT1,PCYT1A
HUMAN_PWY66-428	threonine degradation	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	1738,593,113675	DLD,BCKDHA,SDSL
HUMAN_PWY-6313	serotonin degradation	0.511023346997144	-0.671340000982324	6	3	0.00775193798449612	387	907	4128,6817,217	MAOA,SULT1A1,ALDH2
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.518927691910319	-0.655990727467887	32	14	0.0361757105943152	387	907	23475,6817,169355,64802,8942,10327,125061,29785,23498,5447,4128,1545,8564,217	QPRT,SULT1A1,IDO2,NMNAT1,KYNU,AKR1A1,AFMID,CYP2S1,HAAO,POR,MAOA,CYP1B1,KMO,ALDH2
HUMAN_PWY-6402	superpathway of melatonin degradation	0.540885375590369	-0.614547897648362	11	5	0.0129198966408269	387	907	29785,5447,1545,4128,6817	CYP2S1,POR,CYP1B1,MAOA,SULT1A1
HUMAN_PWY-5972	stearate biosynthesis	0.540885375590369	-0.614547897648362	11	5	0.0129198966408269	387	907	64834,51703,79071,2180,2181	ELOVL1,ACSL5,ELOVL6,ACSL1,ACSL3
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	230,226	ALDOC,ALDOA
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	5208,5209	PFKFB2,PFKFB3
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	7378,978	UPP1,CDA
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	124583,953	CANT1,ENTPD1
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	64802,23475	NMNAT1,QPRT
META_PWY66-368	ketolysis	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	56898,622	BDH2,BDH1
HUMAN_GLUDEG-I-PWY	GABA shunt	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	2752,18	GLUL,ABAT
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	1738,5160	DLD,PDHA1
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	51363,10090	CHST15,UST
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	55577,10007	NAGK,GNPDA1
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	64802,23475	NMNAT1,QPRT
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	51004,23590	COQ6,PDSS1
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	5208,5209	PFKFB2,PFKFB3
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	1738,593	DLD,BCKDHA
HUMAN_PWY66-368	ketolysis	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	56898,622	BDH2,BDH1
META_PWY-7434	terminal O-glycans residues modification	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	2651,6487	GCNT2,ST3GAL3
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	25824,10587	PRDX5,TXNRD2
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	51004,23590	COQ6,PDSS1
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	10090,51363	UST,CHST15
META_PWY-6313	serotonin degradation	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	4128,217	MAOA,ALDH2
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	1738,593	DLD,BCKDHA
HUMAN_PWY-4921	protein citrullination	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	23569,29943	PADI4,PADI1
HUMAN_PWY66-21	ethanol degradation II	0.570594084684112	-0.561077207091187	4	2	0.00516795865633075	387	907	217,55902	ALDH2,ACSS2
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	0.583879253224928	-0.538061075707822	9	4	0.0103359173126615	387	907	6241,1854,84284,6240	RRM2,DUT,NTPCR,RRM1
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.583879253224928	-0.538061075707822	9	4	0.0103359173126615	387	907	6240,1635,84284,6241	RRM1,DCTD,NTPCR,RRM2
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.583879253224928	-0.538061075707822	9	4	0.0103359173126615	387	907	56848,427,130367,56624	SPHK2,ASAH1,SGPP2,ASAH2
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	0.583879253224928	-0.538061075707822	9	4	0.0103359173126615	387	907	220074,1312,4128,217	LRTOMT,COMT,MAOA,ALDH2
HUMAN_PWY-4061	glutathione-mediated detoxification	0.607547958971094	-0.498324162075026	19	8	0.020671834625323	387	907	56267,4259,2950,4258,883,8836,4257,290	KYAT3,MGST3,GSTP1,MGST2,KYAT1,GGH,MGST1,ANPEP
HUMAN_VALDEG-PWY	valine degradation	0.636530630204069	-0.451722739276763	12	5	0.0129198966408269	387	907	586,3030,593,1738,18	BCAT1,HADHA,BCKDHA,DLD,ABAT
HUMAN_LEU-DEG2-PWY	leucine degradation	0.636530630204069	-0.451722739276763	12	5	0.0129198966408269	387	907	1738,549,593,3712,586	DLD,AUH,BCKDHA,IVD,BCAT1
META_PWY-6369	inositol pyrophosphates biosynthesis	0.637400826464037	-0.450356580382174	7	3	0.00775193798449612	387	907	51447,64768,9807	IP6K2,IPPK,IP6K1
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	0.637400826464037	-0.450356580382174	7	3	0.00775193798449612	387	907	51447,64768,9807	IP6K2,IPPK,IP6K1
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.637400826464037	-0.450356580382174	7	3	0.00775193798449612	387	907	6675,10007,2582	UAP1,GNPDA1,GALE
HUMAN_PWY-5067	glycogen biosynthesis	0.637400826464037	-0.450356580382174	7	3	0.00775193798449612	387	907	55276,2992,7360	PGM2,GYG1,UGP2
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2820	GPD2
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	8473	OGT
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	18	ABAT
HUMAN_PWY6666-1	anandamide degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2166	FAAH
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3939	LDHA
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	55349	CHDH
HUMAN_PWY-6620	guanine and guanosine salvage	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	4860	PNP
META_SERDEG-PWY	L-serine degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	113675	SDSL
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	23590	PDSS1
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	4706	NDUFAB1
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2618	GART
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	55253	TYW1
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	1509	CTSD
META_PWY-6118	glycerol-3-phosphate shuttle	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2820	GPD2
META_PWY-5030	L-histidine degradation III	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3034	HAL
HUMAN_PWY-5340	sulfate activation for sulfonation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	9061	PAPSS1
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	55349	CHDH
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	79644	SRD5A3
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2222	FDFT1
HUMAN_PWY-6181	histamine degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3176	HNMT
META_PWY-6620	guanine and guanosine salvage	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	4860	PNP
HUMAN_PWY66-397	resolvin D biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	240	ALOX5
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	5095	PCCA
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	80146	UXS1
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	5447	POR
HUMAN_PWY66-14	MAP kinase cascade	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	5604	MAP2K1
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	55902	ACSS2
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	8473	OGT
HUMAN_PWY-5525	D-glucuronate degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	51084	CRYL1
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3705	ITPK1
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3705	ITPK1
HUMAN_PWY-5386	methylglyoxal degradation I	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	197257	LDHD
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2618	GART
META_PWY-5670	epoxysqualene biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2222	FDFT1
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2618	GART
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	64902	AGXT2
META_PWY3O-4106	NAD salvage pathway III	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	64802	NMNAT1
HUMAN_PWY-4041	gamma-glutamyl cycle	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	55748	CNDP2
META_PWY-5453	methylglyoxal degradation III	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	231	AKR1B1
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2618	GART
META_PWY66-397	resolvin D biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	240	ALOX5
META_PWY-5340	sulfate activation for sulfonation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	9061	PAPSS1
META_PWY-6181	histamine degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3176	HNMT
HUMAN_PWY-5269	cardiolipin biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	9489	PGS1
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	5095	PCCA
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	3613	IMPA2
HUMAN_PWY-6482	diphthamide biosynthesis	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	51611	DPH5
HUMAN_PWY0-1182	trehalose degradation	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	11181	TREH
META_PWY-0	putrescine degradation III	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	217	ALDH2
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	1632	ECI1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.671575750044049	-0.398128462167326	2	1	0.00258397932816537	387	907	2673	GFPT1
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.683274893018817	-0.380858021586531	10	4	0.0103359173126615	387	907	2876,847,2878,6648	GPX1,CAT,GPX3,SOD2
HUMAN_PWY-6398	melatonin degradation I	0.683274893018817	-0.380858021586531	10	4	0.0103359173126615	387	907	1545,5447,6817,29785	CYP1B1,POR,SULT1A1,CYP2S1
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	6241,6240	RRM2,RRM1
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	5009,4942	OTC,OAT
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	6240,6241	RRM1,RRM2
META_PWY-6402	superpathway of melatonin degradation	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	5447,1545	POR,CYP1B1
META_PWY66-378	androgen biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	6715,1586	SRD5A1,CYP17A1
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	55276,2582	PGM2,GALE
META_PWY-7726	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase)	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	60481,9415	ELOVL5,FADS2
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	5160,1738	PDHA1,DLD
META_PWY-4061	glutathione-mediated detoxification I	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	883,56267	KYAT1,KYAT3
META_PWY-6398	melatonin degradation I	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	5447,1545	POR,CYP1B1
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	211,210	ALAS1,ALAD
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	221,55276	ALDH3B1,PGM2
META_PWY-7606	docosahexaenoate biosynthesis III (6-desaturase, mammals)	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	9415,60481	FADS2,ELOVL5
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	211,210	ALAS1,ALAD
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	2673,6675	GFPT1,UAP1
HUMAN_PWY66-367	ketogenesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	56898,622	BDH2,BDH1
META_PWY-6074	zymosterol biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	6307,3930	MSMO1,LBR
META_PWY-6342	noradrenaline and adrenaline degradation	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	1312,217	COMT,ALDH2
HUMAN_PWY66-161	oxidative ethanol degradation III	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	55902,217	ACSS2,ALDH2
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	55500,10390	ETNK1,CEPT1
HUMAN_PWY66-378	androgen biosynthesis	0.708194098507319	-0.345037072426714	5	2	0.00516795865633075	387	907	1586,6715	CYP17A1,SRD5A1
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.718764175930932	-0.330221964030733	13	5	0.0129198966408269	387	907	593,1738,875,4548,5095	BCKDHA,DLD,CBS,MTR,PCCA
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	3615,6240,6241	IMPDH2,RRM1,RRM2
HUMAN_PWY-5994	palmitate biosynthesis	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	4706,344967,109703458	NDUFAB1,LOC344967,HTD2
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	8942,8564,23498	KYNU,KMO,HAAO
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	231,57016,29785	AKR1B1,AKR1B10,CYP2S1
HUMAN_PWY-2201	folate transformations I	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	10797,10840,4548	MTHFD2,ALDH1L1,MTR
META_LEU-DEG2-PWY	L-leucine degradation I	0.738839816649403	-0.302674138431133	8	3	0.00775193798449612	387	907	549,1738,593	AUH,DLD,BCKDHA
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.764640331549902	-0.268349710549771	11	4	0.0103359173126615	387	907	26090,3990,119548,11343	ABHD12,LIPC,PNLIPRP3,MGLL
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.764640331549902	-0.268349710549771	11	4	0.0103359173126615	387	907	2222,3930,6307,6309	FDFT1,LBR,MSMO1,SC5D
META_PWY66-341	cholesterol biosynthesis I	0.764640331549902	-0.268349710549771	11	4	0.0103359173126615	387	907	6309,6307,2222,3930	SC5D,MSMO1,FDFT1,LBR
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.764640331549902	-0.268349710549771	11	4	0.0103359173126615	387	907	6309,6307,3930,2222	SC5D,MSMO1,LBR,FDFT1
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.786791329840301	-0.23979221204968	14	5	0.0129198966408269	387	907	2180,1632,2181,3032,51703	ACSL1,ECI1,ACSL3,HADHB,ACSL5
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	0.806779474265181	-0.214704914146404	6	2	0.00516795865633075	387	907	6240,6241	RRM1,RRM2
HUMAN_PWY-6074	zymosterol biosynthesis	0.806779474265181	-0.214704914146404	6	2	0.00516795865633075	387	907	3930,6307	LBR,MSMO1
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.806779474265181	-0.214704914146404	6	2	0.00516795865633075	387	907	79071,2180	ELOVL6,ACSL1
META_ILEUDEG-PWY	L-isoleucine degradation I	0.806779474265181	-0.214704914146404	6	2	0.00516795865633075	387	907	593,1738	BCKDHA,DLD
HUMAN_PWY66-373	sucrose degradation	0.806779474265181	-0.214704914146404	6	2	0.00516795865633075	387	907	226,230	ALDOA,ALDOC
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	4942	OAT
META_PWY66-221	nicotine degradation V	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	316	AOX1
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	1586	CYP17A1
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	231	AKR1B1
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	2752	GLUL
META_PWY-5331	taurine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	84890	ADO
HUMAN_PWY-6100	L-carnitine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	223	ALDH9A1
META_PWY-6100	L-carnitine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	223	ALDH9A1
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	4548	MTR
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	9562	MINPP1
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	10007	GNPDA1
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	32	ACACB
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	4548	MTR
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	10327	AKR1A1
META_PWY66-381	glucocorticoid biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	1586	CYP17A1
HUMAN_PWY-5331	taurine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	84890	ADO
HUMAN_PWY-7283	wybutosine biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	55253	TYW1
META_GLUDEG-I-PWY	GABA shunt	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	18	ABAT
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	231	AKR1B1
HUMAN_PWY66-392	lipoxin biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	240	ALOX5
META_PWY-7185	UTP and CTP dephosphorylation I	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	953	ENTPD1
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	84284	NTPCR
META_PWY-6875	retinoate biosynthesis II	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	7498	XDH
META_PWY-7177	UTP and CTP dephosphorylation II	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	953	ENTPD1
META_PWY66-392	lipoxin biosynthesis	0.812017943121867	-0.208232841623881	3	1	0.00258397932816537	387	907	240	ALOX5
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.812133550895539	-0.208090480798191	25	9	0.0232558139534884	387	907	137964,253558,84803,10555,84649,56894,56895,10162,116255	GPAT4,LCLAT1,GPAT3,AGPAT2,DGAT2,AGPAT3,AGPAT4,LPCAT3,MOGAT1
HUMAN_PWY-7527	methionine salvage cycle III	0.816320098364247	-0.202948723531532	9	3	0.00775193798449612	387	907	27430,4144,4507	MAT2B,MAT2A,MTAP
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.828695182225464	-0.187902884797395	12	4	0.0103359173126615	387	907	1738,593,3030,586	DLD,BCKDHA,HADHA,BCAT1
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.828695182225464	-0.187902884797395	12	4	0.0103359173126615	387	907	3295,51703,2180,2181	HSD17B4,ACSL5,ACSL1,ACSL3
META_PWY-922	mevalonate pathway I	0.873339472086358	-0.135430941813292	10	3	0.00775193798449612	387	907	3422,10654,3156	IDI1,PMVK,HMGCR
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.873339472086358	-0.135430941813292	10	3	0.00775193798449612	387	907	978,7084,1633	CDA,TK2,DCK
HUMAN_PWY-922	mevalonate pathway	0.873339472086358	-0.135430941813292	10	3	0.00775193798449612	387	907	3422,10654,3156	IDI1,PMVK,HMGCR
META_PWY-7224	purine deoxyribonucleosides salvage	0.874530933388338	-0.134067612492317	7	2	0.00516795865633075	387	907	1716,1633	DGUOK,DCK
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.874530933388338	-0.134067612492317	7	2	0.00516795865633075	387	907	1757,55349	SARDH,CHDH
HUMAN_PWY66-221	nicotine degradation III	0.874530933388338	-0.134067612492317	7	2	0.00516795865633075	387	907	29785,316	CYP2S1,AOX1
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	6241,2618,6240,3615	RRM2,GART,RRM1,IMPDH2
HUMAN_PWY66-341	cholesterol biosynthesis I	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	6307,6309,2222,3930	MSMO1,SC5D,FDFT1,LBR
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	3295,51703,2180,2181	HSD17B4,ACSL5,ACSL1,ACSL3
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	6307,6309,3930,2222	MSMO1,SC5D,LBR,FDFT1
META_PWY-6861	the visual cycle I (vertebrates)	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	6121,6017,10170,5948	RPE65,RLBP1,DHRS9,RBP2
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	1854,6240,84284,6241	DUT,RRM1,NTPCR,RRM2
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.877553407247642	-0.130617462533915	13	4	0.0103359173126615	387	907	3930,2222,6307,6309	LBR,FDFT1,MSMO1,SC5D
HUMAN_PWY66-380	estradiol biosynthesis I	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	51170	HSD17B11
META_ARGININE-SYN4-PWY	L-ornithine biosynthesis II	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	4942	OAT
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	5447	POR
HUMAN_PWY-6117	spermine and spermidine degradation I	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	6303	SAT1
HUMAN_PWY-2161	folate polyglutamylation	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	2356	FPGS
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	4942	OAT
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	4351	MPI
META_PWY-3781	aerobic respiration I (cytochrome c)	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	6390	SDHB
HUMAN_PWY-6875	retinoate biosynthesis II	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	7498	XDH
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	51699	VPS29
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	51268	PIPOX
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	80150	ASRGL1
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	2950	GSTP1
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	3422	IDI1
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	2992	GYG1
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	2806	GOT2
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	6611	SMS
HUMAN_PWY-4984	urea cycle	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	5009	OTC
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	6817	SULT1A1
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	3422	IDI1
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	2806	GOT2
META_PWY-6158	creatine-phosphate biosynthesis	0.892492562607524	-0.113737098575922	4	1	0.00258397932816537	387	907	1152	CKB
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.904634345840316	-0.100224454672961	25	8	0.020671834625323	387	907	6484,11227,56913,11226,2650,6482,2590,6483	ST3GAL4,GALNT5,C1GALT1,GALNT6,GCNT1,ST3GAL1,GALNT2,ST3GAL2
META_FAO-PWY	fatty acid beta-oxidation I	0.913858238211562	-0.0900798199822882	14	4	0.0103359173126615	387	907	2180,2181,3032,51703	ACSL1,ACSL3,HADHB,ACSL5
META_PWY-5004	superpathway of L-citrulline metabolism	0.914101649788184	-0.0898134995015615	11	3	0.00775193798449612	387	907	5009,4843,4942	OTC,NOS2,OAT
META_PWY66-5	superpathway of cholesterol biosynthesis	0.923754422435055	-0.0793090192507465	23	7	0.0180878552971576	387	907	6309,6307,3422,2222,3930,3156,10654	SC5D,MSMO1,IDI1,FDFT1,LBR,HMGCR,PMVK
HUMAN_PWY-5030	histidine degradation	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	3034	HAL
META_PWY66-201	nicotine degradation IV	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	316	AOX1
META_PWY-4983	L-citrulline-nitric oxide cycle	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	4843	NOS2
META_PWY-6111	mitochondrial L-carnitine shuttle	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	1374	CPT1A
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	4843	NOS2
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	1757	SARDH
HUMAN_PWY-3661-1	glycine betaine degradation	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	1757	SARDH
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	6817	SULT1A1
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	1374	CPT1A
HUMAN_PWY66-241	bupropion degradation	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	29785	CYP2S1
META_PWY-4984	urea cycle	0.938567178638029	-0.0634008446563817	5	1	0.00258397932816537	387	907	5009	OTC
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.940246968039569	-0.0616127062690958	15	4	0.0103359173126615	387	907	84284,6240,1635,6241	NTPCR,RRM1,DCTD,RRM2
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.940246968039569	-0.0616127062690958	15	4	0.0103359173126615	387	907	1854,84284,6240,6241	DUT,NTPCR,RRM1,RRM2
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.940246968039569	-0.0616127062690958	15	4	0.0103359173126615	387	907	5948,10170,6017,6121	RBP2,DHRS9,RLBP1,RPE65
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.94257047231194	-0.0591445907714784	12	3	0.00775193798449612	387	907	3422,3156,10654	IDI1,HMGCR,PMVK
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	0.94257047231194	-0.0591445907714784	12	3	0.00775193798449612	387	907	51170,1586,6715	HSD17B11,CYP17A1,SRD5A1
META_PWY-6857	retinol biosynthesis	0.94257047231194	-0.0591445907714784	12	3	0.00775193798449612	387	907	5948,10170,1066	RBP2,DHRS9,CES1
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.94257047231194	-0.0591445907714784	12	3	0.00775193798449612	387	907	3156,10654,3422	HMGCR,PMVK,IDI1
META_PWY-7305	superpathway of steroid hormone biosynthesis	0.949315936287967	-0.0520136208256556	9	2	0.00516795865633075	387	907	1586,6715	CYP17A1,SRD5A1
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.959052942164459	-0.0418090000286666	25	7	0.0180878552971576	387	907	3422,2222,3930,10654,3156,6307,6309	IDI1,FDFT1,LBR,PMVK,HMGCR,MSMO1,SC5D
META_PWY66-367	ketogenesis	0.964924719516955	-0.0357051915494162	6	1	0.00258397932816537	387	907	622	BDH1
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.964924719516955	-0.0357051915494162	6	1	0.00258397932816537	387	907	3615	IMPDH2
META_PWY-5327	superpathway of L-lysine degradation	0.964924719516955	-0.0357051915494162	6	1	0.00258397932816537	387	907	35	ACADS
META_PWY-7455	allopregnanolone biosynthesis	0.964924719516955	-0.0357051915494162	6	1	0.00258397932816537	387	907	6715	SRD5A1
HUMAN_PWY-7455	allopregnanolone biosynthesis	0.964924719516955	-0.0357051915494162	6	1	0.00258397932816537	387	907	6715	SRD5A1
HUMAN_PWY66-201	nicotine degradation IV	0.96831005234103	-0.0322029409861003	10	2	0.00516795865633075	387	907	316,29785	AOX1,CYP2S1
HUMAN_PWY-6857	retinol biosynthesis	0.972277859761601	-0.0281136514207481	17	4	0.0103359173126615	387	907	3990,1066,10170,5948	LIPC,CES1,DHRS9,RBP2
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.975513381756074	-0.0247914011698271	41	12	0.0310077519379845	387	907	205,353,100,204,122481,132,159,509,3615,6240,4860,6241	AK4,APRT,ADA,AK2,AK7,ADK,ADSS,ATP5F1C,IMPDH2,RRM1,PNP,RRM2
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.979896156763261	-0.0203086754184091	21	5	0.0129198966408269	387	907	205,509,122481,159,204	AK4,ATP5F1C,AK7,ADSS,AK2
META_PWY-6872	retinoate biosynthesis I	0.979990350542045	-0.0202125537516641	7	1	0.00258397932816537	387	907	216	ALDH1A1
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.98035636402007	-0.0198391366621667	11	2	0.00516795865633075	387	907	6240,6241	RRM1,RRM2
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	0.98035636402007	-0.0198391366621667	11	2	0.00516795865633075	387	907	6241,6240	RRM2,RRM1
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.983970481975907	-0.0161593803717964	15	3	0.00775193798449612	387	907	3615,6240,6241	IMPDH2,RRM1,RRM2
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.987913542364409	-0.012160092791625	12	2	0.00516795865633075	387	907	1633,1716	DCK,DGUOK
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.987913542364409	-0.012160092791625	12	2	0.00516795865633075	387	907	1593,5447	CYP27A1,POR
HUMAN_PWY-6872	retinoate biosynthesis I	0.988594499816436	-0.0114710417334584	8	1	0.00258397932816537	387	907	216	ALDH1A1
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.989716828582536	-0.0103364085031929	16	3	0.00775193798449612	387	907	1633,7084,978	DCK,TK2,CDA
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.993504320260587	-0.00651686847371478	9	1	0.00258397932816537	387	907	29880	ALG5
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.994686294944803	-0.00532787299770343	21	4	0.0103359173126615	387	907	6240,84284,1854,6241	RRM1,NTPCR,DUT,RRM2
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.998135106808074	-0.00186663427018801	40	9	0.0232558139534884	387	907	205,204,122481,159,509,6240,3615,6241,2618	AK4,AK2,AK7,ADSS,ATP5F1C,RRM1,IMPDH2,RRM2,GART
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.998806131024957	-0.0011945822043328	12	1	0.00258397932816537	387	907	3615	IMPDH2
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-5766	L-glutamate degradation X	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY0-662	PRPP biosynthesis I	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PROUT-PWY	L-proline degradation	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-6145	superpathway of CMP-sialic acids biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999990813	-9.18742859568056e-12	2	0	0	387	907
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY66-382	mineralocorticoid biosynthesis	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY66-301	catecholamine biosynthesis	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY66-387	fatty acid alpha-oxidation II	0.999999999997592	-2.40822639607785e-12	3	0	0	387	907
META_PWY-5905	hypusine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5686	UMP biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5329	L-cysteine degradation III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-1722	formate assimilation into 5,10-methylenetetrahydrofolate	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6938	NADH repair	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5326	sulfite oxidation IV	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY66-420	carnosine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5326	sulfite oxidation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6132	lanosterol biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-40	putrescine biosynthesis I	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY66-241	bupropion degradation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-7306	estradiol biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY66-366	flavin biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6012-1	acyl carrier protein activation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY66-388	fatty acid alpha-oxidation III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-46	putrescine biosynthesis I	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and transhydrogenation	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6938	NADH repair	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5329	L-cysteine degradation II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-46	putrescine biosynthesis III	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
META_PWY-6132	lanosterol biosynthesis	1.00000000000011	1.10911280160053e-13	1	0	0	387	907
HUMAN_PWY-5177	glutaryl-CoA degradation	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
META_PWY-6823	molybdenum cofactor biosynthesis	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
META_PWY-7205	CMP phosphorylation	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000199	1.98947802676486e-12	4	0	0	387	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000632	6.32446178761015e-12	5	0	0	387	907
HUMAN_PWY-5996	oleate biosynthesis	1.00000000000994	9.93773206087178e-12	6	0	0	387	907
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000994	9.93773206087178e-12	6	0	0	387	907
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000001309	1.30909545356661e-11	7	0	0	387	907
HUMAN_PWY-7205	CMP phosphorylation	1.00000000002018	2.01847982501512e-11	10	0	0	387	907
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000002087	2.08715952371629e-11	11	0	0	387	907
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000002328	2.32812344706443e-11	12	0	0	387	907
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000002619	2.61854612208871e-11	14	0	0	387	907
